Case Studies in Foreign Particulate Analysis
Topics covered include analytical techniques and methods suitable for API particle sizing and in vitro bioequivalence for nasal drug products as well as preparation methods and a review of case…
A 2013 AAPS Annual Meeting Recap
For the third consecutive year Gateway had the pleasure of exhibiting at the AAPS Annual Meeting, which was held this year in San Antonio, at the very large Henry B. Gonzalez…
AAPS 2017 Development and Validation of a cGMP Compliant Particulate Characterization Database
Reference databases catalog data and information for known materials, process and product related materials, and archived foreign particulate.
Materials Testing Services
Watch our video on Gateway Analytical's materials testing services.
Gateway Analytical Acquires RapID System to Meet Growing Market Demand
PITTSBURGH, January, 21 2014 — Gateway Analytical announced today that they have acquired the RapID SPE-ls raman.ID + metal.ID® system, the latest technology in automated particle identification. This acquisition enhances…
RDD 2012: Investigation of the Microstructure of Combination Dry Powder Inhaler Formulations by Atomic Force Microscopy and Raman Chemical Imaging
May 20, 2012 The microstructure of combination DPI formulations is complex and is related to the surface interfacial interactions between components of the formulation, which define the structure and thereby performance of the formulation (1, 2, 3). Previous studies have attempted to investigate the microstructure of combination DPI formulations using…
A Forensic Approach to Particulate Contamination in Inhalable Drug Products
Authors & ContributorsRebekah ByrneDavid Exline
Gateway Analytical Receives Controlled Substance Registration Certificate from the Drug Enforcement Administration
Gateway Analytical is proud to announce that we have obtained our Controlled Substance Registration Certificate issued by the United States Department of Justice Drug Enforcement Administration’s Office of Diversion Control.…
Addressing Glass Delamination Concerns Proactively with USP 1660 Testing
Glass delamination is, indeed, a serious issue which can not only cause pharmaceutical companies millions of dollars in recalls.